Superordinate regulatory framework conditions and their subsequent incentives must not conflict with the ethical principles of medical care, especially the primary orientation to patient welfare. Institutional and individual healthcare providers have a responsibility towards patients first and only secondarily for an economically appropriate spending of public resources. The provision of medical care for people must enable an adequate livelihood. Institutional maximization of profits is to be avoided, especially concerning financial investors. In the corona pandemic, economic disincentives are becoming apparent and necessitate readjustments. Possible recommendations for action are the empowerment of the medical profession and management to engage in a qualified exchange.
Keyphrases
- healthcare
- end stage renal disease
- ejection fraction
- sars cov
- newly diagnosed
- minimally invasive
- chronic kidney disease
- coronavirus disease
- transcription factor
- emergency department
- mental health
- palliative care
- peritoneal dialysis
- machine learning
- magnetic resonance
- diffusion weighted imaging
- clinical practice
- coronary artery disease
- hepatitis c virus
- human immunodeficiency virus
- patient reported outcomes
- decision making
- health insurance
- adverse drug